Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cell-based immunotherapy for malignant gliomas.

Yasuharu Akasaki1, Keith L Black, John S Yu

  • 1Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Suite 800 East, 8631 West 3 Street, Los Angeles, CA 90048, USA.

Expert Review of Neurotherapeutics
|July 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Refined Endoscopic Extracapsular Resection Technique for Pituitary Adenomas With Suprasellar Extension: A Retrospective Analysis of 259 Cases.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

Recurrent ophthalmic arteries supplying posterior meningiomas: embryologic background and 3D anatomical visualization.

BMC surgery·2026
Same author

Sex-specific retina-brain signatures link ERα/ERβ imbalance with gliosis in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same author

Improving the definition of glioblastoma resection borders with intraoperative cone-beam computed tomography.

Surgical neurology international·2026
Same author

Long-term follow up of malignant transformation of epidermoid cyst at the cerebellopontine angle based on serial imaging findings; A case report and literature review.

International cancer conference journal·2026
Same author

Milky cerebrospinal fluid without infection during endoscopic hematoma removal: illustrative case.

Journal of neurosurgery. Case lessons·2026

Dendritic cell immunotherapy shows promise for malignant gliomas, but a cure likely requires combining treatments. This approach leverages the immune system to fight brain tumors effectively.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer Therapy

Background:

  • Malignant gliomas have a poor prognosis despite advances in conventional treatments.
  • The central nervous system (CNS) is not inherently immune-privileged and can clear tumor cells.
  • Gliomas develop sophisticated mechanisms to evade immune surveillance and suppress anti-tumor responses.

Purpose of the Study:

  • To review dendritic cell-based immunotherapeutic strategies for malignant gliomas.
  • To discuss the outcomes of recent clinical trials involving these approaches.
  • To explore the potential of combination therapies for treating these aggressive brain tumors.

Main Methods:

  • Review of current literature on CNS immune responses and glioma immunology.
  • Analysis of clinical trial data for dendritic cell-based immunotherapies.

Related Experiment Videos

  • Discussion of immune evasion strategies employed by gliomas.

    • Main Results:

    • Dendritic cell-based immunotherapy is a promising avenue for glioma treatment.
    • Glioma heterogeneity and immune-refractory cells present significant challenges.
    • Current treatments often fail to overcome the complex immune suppression mechanisms of gliomas.

    Conclusions:

    • Dendritic cell immunotherapy is a potential treatment for malignant gliomas.
    • Effective treatment likely necessitates a multimodal strategy combining various therapeutic modalities.
    • Targeting diverse tumor characteristics through rational combination therapies may offer the most effective strategy against malignant gliomas.